Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 6,854.0 | $541K | 0.47% | NEW | — | $78.99 | +43.2% |
| 22 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 8,026.0 | $540K | 0.47% | NEW | — | $67.30 | +18.2% |
| 23 | EYPT | EYEPOINT INC | Healthcare | 29,530.0 | $540K | 0.47% | NEW | — | $18.27 | -30.9% |
| 24 | ALKS | ALKERMES PLC | Healthcare | 19,280.0 | $539K | 0.47% | NEW | — | $27.98 | +90.6% |
| 25 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 6,800.0 | $538K | 0.47% | NEW | — | $79.11 | -28.8% |
| 26 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 14,818.0 | $538K | 0.47% | NEW | — | $36.29 | -26.1% |
| 27 | ACLX | ARCELLX INC | Healthcare | 8,224.0 | $536K | 0.47% | NEW | — | $65.20 | +76.5% |
| 28 | PTCT | PTC THERAPEUTICS INC | Healthcare | 7,046.0 | $535K | 0.47% | NEW | — | $75.96 | +4.3% |
| 29 | — | ZYMEWORKS INC | — | 20,312.0 | $535K | 0.47% | NEW | — | $26.33 | — |
| 30 | SUPN | SUPERNUS PHARMACEUTICALS INC | Healthcare | 10,758.0 | $535K | 0.47% | NEW | — | $49.70 | -4.9% |
| 31 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 6,121.0 | $535K | 0.47% | NEW | — | $87.34 | +56.5% |
| 32 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 14,283.0 | $534K | 0.47% | NEW | — | $37.42 | -5.2% |
| 33 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 24,621.0 | $534K | 0.47% | NEW | — | $21.70 | +63.3% |
| 34 | RPRX | ROYALTY PHARMA PLC | Healthcare | 13,826.0 | $534K | 0.47% | NEW | — | $38.64 | +52.7% |
| 35 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 44,223.0 | $534K | 0.47% | NEW | — | $12.08 | +48.5% |
| 36 | LQDA | LIQUIDIA CORPORATION | Healthcare | 15,485.0 | $534K | 0.47% | NEW | — | $34.49 | +160.2% |
| 37 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 6,519.0 | $534K | 0.47% | NEW | — | $81.88 | -29.6% |
| 38 | PVLA | PALVELLA THERAPEUTICS INC NE | Healthcare | 5,084.0 | $532K | 0.47% | NEW | — | $104.67 | +37.1% |
| 39 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 17,506.0 | $531K | 0.46% | NEW | — | $30.34 | +36.5% |
| 40 | TGTX | TG THERAPEUTICS INC | Healthcare | 17,807.0 | $531K | 0.46% | NEW | — | $29.81 | +81.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%